Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
Highlights • The small molecule inhibitor of the inflammasome, MC950, attenuates Aβ+LPS-induced inflammasome activation in microglia. • It increases phagocytosis of Aβ by microglia in vitro. • Oral administration of MC950, reduces Aβ accumulation in APP/PS1 mice. • This is accompanied by improved co...
Saved in:
Published in | Brain, behavior, and immunity Vol. 61; pp. 306 - 316 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Inc
01.03.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Highlights • The small molecule inhibitor of the inflammasome, MC950, attenuates Aβ+LPS-induced inflammasome activation in microglia. • It increases phagocytosis of Aβ by microglia in vitro. • Oral administration of MC950, reduces Aβ accumulation in APP/PS1 mice. • This is accompanied by improved cognitive function and decreased neuroinflammation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0889-1591 1090-2139 |
DOI: | 10.1016/j.bbi.2016.12.014 |